Modulators of soluble guanylyl cyclase

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 358, Issue 1, 1998, Pages 123-126

  Koesling, Doris ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; GUANYLATE CYCLASE; HISTIDINE; NITRIC OXIDE SYNTHASE INHIBITOR; OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; UNCLASSIFIED DRUG;

ALLOSTERISM; ENZYME ACTIVATION; ENZYME BINDING; ENZYME REGULATION; ENZYME STRUCTURE; HUMAN; HUMAN CELL; INHIBITION KINETICS; REVIEW; SPECTROPHOTOMETRY;

ANIMALS; ENZYME ACTIVATION; GUANYLATE CYCLASE; HUMANS; NITRIC OXIDE; NITRIC OXIDE DONORS;

EID: 0031813798     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005232     Document Type: Review

References (29)

1. + currents in frog. Br J Pharmacol 121:1369-1377
2. 2 subunit of soluble guanylyl cyclase contains an insert homologous to a region within adenylyl cyclases and functions as a dominant negative protein. J Biol Chem 270:21109-21113
3. Brüne B, Schmidt K-U, Ullrich V (1990) Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion. Eur J Biochem 192:683-686
4. Brunner F, Schmidt K, Nielsen HB, Mayer B (1996) Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J Pharmacol Exp Ther 277:48-53
5. 1 subunits. Bur J Biochem 240:380-386
6. Friebe A, Koesling D (1998) Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol Pharmacol (in press)
7. Friebe A, Schultz G, Koesling D (1996) Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J 15:6863-6868
8. 1H-[1,2,4]oxadiazolo[4,3-α]quinoxalin-1-one (ODQ). Mol Pharmacol 48:185-188
9. Gerzer R, Böhme E, Hofmann F, Schultz G (1981b) Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett 132:71-74
10. Gerzer R, Hofmann F, Schultz G (1981a) Purification of a soluble, sodium-nitroprusside-stimulated guanylate cyclase from bovine lung. Eur J Biochem 116:479-486
11. Humbert P, Niroomand F, Fischer G, Mayer B, Koesling D, Hinsch KD, Gausepohl H, Frank R, Schultz G, Böhme E (1990) Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method. Eur J Biochem 190:273-278
12. Ignarro IJ, Degnan JN, Baricos WH, Kadowitz PJ, Wolin MS (1982a) Activation of purified guanylate cyclase by nitric oxide requires heme: comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochim Biophys Acta 718:49-59
13. Ignarro LJ, Wood KS, Wolin MS (1982b) Activation of purified soluble guanylate cyclase by protoporphyrin IX. Proc Natl Acad Sci USA 79:2870-2873
14. Kharitonov VG, Russwurm M, Magde D, Sharmu VS, Koesling D (1997) Dissociation of nitric oxide from soluble guanylyl cyclase. Biochem Biophys Res Commun 239:284-286
15. Koesling D, Böhme E, Schultz O (1991) Guanylyl cyclases, a growing family of signal transducing enzymes. FASEB J 5:2785-2791
16. Moncada S, Higgs EA (1995) Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9:1319-1330
17. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142
18. Mülsch A, Bauersachs J, Schäfer A, Stasch JP, Kast R, Busse R (1997) Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br J Pharmacol 120:681-689
19. Russwurm M, Behrends S, Harteneck C, Koesling D (1998) Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. (in press)
20. Schmidt H, Walter U (1994) NO at work. Cell 78:919-925
21. 1H-[1,2,4]oxadiazolo[4,3-α]quinoxalin-1-one (ODQ) as a heme site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol Pharmacol 50:1-5
22. Stone JR, Marietta MA (1994) Soluble guanylyl cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterisation of the ferrous and ferric states. Biochemistry 33:5636-5640
23. Stone JR, Marietta MA (1995) Heme stoichiometry of heterodimeric soluble guanylate cyclase. Biochemistry 34:14668-14674
24. Teng CM, Wu CC, Ko FN, Lee FY, Kuo SC (1997) YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice. Eur J Pharmacol 320:161-166
25. Tomita T, Tsuyama S, Imai Y, Kitagawa T (1997) Purification of bovine soluble guanylate cyclase and ADP-ribosylation on its small subunit by bacterial toxins. J Biochem 122:531-536
26. 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase. Proc Natl Acad Sci USA 91:2592-2596
27. Wegener JW, Nawrath H (1997) Differential effects of isoliquiritigenin and YC-1 in rat aortic smooth muscle. Eur J Pharmacol 3203:89-91
28. Wilson EM, Chinkers M (1995) Identification of sequences mediating guanylyl cyclase dimerisation. Biochemistry 34:4696-4701
29. Wu CC, Ko EN, Kuo SC, Lee FY, Teng CM (1995) YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br J Pharmacol 116:1973-1978